| Analysis | Metabolite Name | Measured Value | Units | diabetes | time of day |
|---|---|---|---|---|---|
| Reversed phase (early) POSITIVE ION MODE | 3-ureidopropionate | 0.6088 | VolNormImp Area counts | db/db | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | 3-ureidopropionate | 0.6683 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | 3-ureidopropionate | 0.8973 | VolNormImp Area counts | db/m | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | 3-ureidopropionate | 0.9356 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | 3-ureidopropionate | 0.9391 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | 3-ureidopropionate | 0.9691 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | 3-ureidopropionate | 1.0923 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | 3-ureidopropionate | 1.1508 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | 3-ureidopropionate | 1.2336 | VolNormImp Area counts | db/m | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | 3-ureidopropionate | 1.2541 | VolNormImp Area counts | db/db | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | 3-ureidopropionate | 1.3317 | VolNormImp Area counts | db/db | ZT5 |
| Reversed phase (early) POSITIVE ION MODE | 3-ureidopropionate | 1.4063 | VolNormImp Area counts | db/m | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | 3-ureidopropionate | 1.7922 | VolNormImp Area counts | db/m | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | 3-ureidopropionate | 1.9174 | VolNormImp Area counts | db/db | ZT17 |
| Reversed phase (early) POSITIVE ION MODE | 3-ureidopropionate | 2.8504 | VolNormImp Area counts | db/db | ZT5 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|